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Eukaryotic phosphatidylinositol transfer protein is a
ubiquitous multifunctional protein that transports
phospholipids between membrane surfaces and partici-
pates in cellular phospholipid metabolism during signal
transduction and vesicular trafficking. The three-di-
mensional structure of the a-isoform of rat phosphati-
dylinositol transfer protein complexed with one mole-
cule of phosphatidylcholine, one of its physiological
ligands, has been determined to 2.2 Å resolution by x-ray
diffraction techniques. A single b-sheet and several long
a-helices define an enclosed internal cavity in which a
single molecule of the phospholipid is accommodated
with its polar head group in the center of the protein
and fatty acyl chains projected toward the surface.
Other structural features suggest mechanisms by which
cytosolic phosphatidylinositol transfer protein inter-
acts with membranes for lipid exchange and associates
with a variety of lipid and protein kinases.
Phosphatidylinositol transfer proteins (PITPs)1 constitute a
highly conserved family of proteins in multicellular animals,
with members in species ranging from Homo sapiens to Dictyo-
stelium discoideum (reviewed in Refs. 1–2, see also Refs. 3–5).
PITPs catalyze an exchange of phosphatidylinositol (PtdIns) or
phosphatidylcholine (PtdCho) molecules between the surfaces
of biological or artificial membranes. The protein appears to be
multifunctional, with cellular functions ranging from inter-
membrane phospholipid transport to possible substrate pres-
entation to lipid-modifying enzymes. Exogenous PITP is able to
restore hormone-stimulated G protein-coupled activation of
PtdIns(4,5)P2 hydrolysis in human promyelocytic cells (6) and
to reconstitute Ca21-stimulated, ATP-dependent secretion of
catecholamines in rat pheochromocytoma cells (7). A variety of
cultured mammalian cells respond to peptide agonists, epider-
mal growth factor, and antigens for the IgE receptor with a
PITP-dependent stimulation of PtdIns 4-kinase and phospho-
lipase C (8–9). PITP and PtdIns 3-kinase together exhibit a
capacity to phosphorylate PtdIns to PtdIns(3)P (10). In cell-free
systems the budding of vesicles from the trans-Golgi network
and vesicle transport between cis and medial Golgi compart-
ments are both stimulated by PITP (11–12). Existence of PITP-
containing multiprotein complexes has been proposed, poised
to respond to extracellular stimuli and to channel PtdIns effi-
ciently from PITP to kinases and phospholipases for the gen-
eration of signal transducing molecules and regulation of ve-
sicular trafficking (13–14).
Multiple isoforms of cytosolic, 32-kDa PITPs are common
and ubiquitous (15–16). Mammalian PITPa and PITPb share
nearly 80% sequence identity; both isoforms are capable of
forming noncovalent and stoichiometric complexes with PtdIns
or PtdCho and transporting these lipid substrates through an
aqueous environment. Sequence identity is more than 98%
among mammalian PITPa isoforms (Fig. 1). PITPa and PITPb
represent unique gene products (17p13.3 and 22q12.1, respec-
tively, in humans) and they exhibit differential tissue expres-
sion. The N terminus of the 140-kDa membrane-associated
retinal degeneration B proteins (rdgBs) contains a region ho-
mologous to the soluble PITPs (17–20). Significantly, the rdgB-
PITP region, comprising 266 amino acids, can be expressed as
a soluble protein that exhibits both PtdIns and PtdCho transfer
activities. We have solved the structure of rat PITPa bound to
phosphatidylcholine using x-ray diffraction techniques. The
results provide a framework for understanding the interactions
of PITPs with lipid molecules and membrane surfaces in lipid
transport processes and with other cellular proteins during
signaling and trafficking events.
EXPERIMENTAL PROCEDURES
Protein Preparation and Crystallization—There were two criteria
that guided all crystallization experiments: use of unmodified protein
and maintenance of a protein-bound ligand of physiological signifi-
cance. Considerable biochemical data have accumulated indicating that
the C-terminal residues of PITP exhibit a conformational change upon
binding to membranes. We therefore avoided the use of truncated or
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tagged proteins, particularly at the C-terminus. To improve the likeli-
hood that a bound phospholipid would be observed in the x-ray data, no
detergents of any kind were employed in any step of purification or
crystallization. Cells of Escherichia coli B834(DE3), a methionine aux-
otroph containing plasmids for expression of groELS and rat PITPa
(21), were grown in chemically defined media at 20 °C with selenome-
thionine in place of methionine (22). The selenomethionyl-substituted
protein was purified by established procedures for the wild-type protein
and the bound bacterial phosphatidylglycerol (PtdGro) was replaced
with sn-1,2-dioleoyl-PtdCho (21). The protein was crystallized under
similar conditions as the wild-type protein when supplemented with
seeding (23).
Structure Determination and Analysis—For x-ray data collection,
crystals were mounted from the crystallization drop in a fiber loop and
frozen directly in a cold nitrogen stream using an ADSC cryostat.
Frozen crystals were sent to NSLS beamline X12C for “Fed-Ex Data
Collection” on a Brandeis B4 CCD detector. The crystal structure of the
PITPazPtdCho complex was solved by multiwavelength anomalous dif-
fraction (MAD) methods (24). A three-wavelength MAD x-ray data set
was collected, with one wavelength at the selenium absorption edge,
one at the absorption peak, and one at a low energy remote (Table I).
Five of the eight selenium sites were identified by SOLVE (25) and
refined by SHARP (26). The resulting electron density map was modi-
fied by solvent flipping as implemented in SOLOMON (27). From the
resulting electron density map, the dominant secondary structure ele-
ments were traced. The final model was built through several cycles of
manual model building with O (28), followed by refinement with CNS
(29). The program DALI (30) was used to determine structurally related
proteins. The lipid cavity was defined and volumes calculated using the
CAST (31) web-server.
FIG. 1. Sequence alignment of the PITP and rdgB proteins. Amino acids showing absolute conservation among all PITP and rdgB proteins
are highlighted in red. Amino acids exhibiting 80–99% conserved identities are highlighted in yellow. Species nomenclature is as follows: RN,
Rattus norvegicus; HS, H. sapien; OC, Oryctolagus cuniculus; MM, Mus musculus; DM, Drosophilia melanogaster; DD, D. discoideum; CE, C.
elegans.
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RESULTS
The protein features a large concave b-sheet and several long
a-helices (Fig. 2). The eight-stranded b-sheet, strands 1 to 8,
has a connectivity of 71865432. The b-sheet is antiparallel,
except for the orientation of strands 1 and 7, which are parallel.
There are three long a-helices, composed of 5 to 7 turns (A, F,
and G), and four shorter a-helices, each with less than two
complete turns (B, C, D, and E). Helices A and F are oriented on
the interior side of the b-sheet, with helix A aligned coincident
with strand 2 and helix F oriented diagonally across the
b-sheet. The phospholipid is clearly visible in the electron den-
sity map (Fig. 3), with the binding site between the interior side
of the b-sheet and a-helices A and F.
Several regions of the electron density map were difficult to
model. These areas consisted of residues 239–242 connecting
helix F to G (containing one of the undetected selenium sites at
Met241) and residues 263–271 at the C terminus. The solvent-
exposed side chain density of residues on helix G is somewhat
weak, although the interior, buried sidechain density is unam-
biguous. The solvent-exposed Met247 has very weak side chain
density and is one of the undetected selenium sites from the
MAD data. The last undetected selenium site is residue 1, for
which no electron density is observed.
Three Functional Regions of PITP—We designate the domi-
nant region of the PITP structure as the lipid-binding core.
This region, a cavity in which the phospholipid molecule binds,
is formed by a-helices A and F and the b-sheet. Limited seg-
ments of helices A and F and strands 4 and 5 are amphipathic
and provide excellent hydrophobic interaction with the phos-
polipid molecule (Fig. 4). The lipid-binding core comprises res-
idues 1–118 and 191–232. Examination of the PITP structure
reveals that the intervening residues 119–190 form an exten-
FIG. 2. A ribbon diagram of the folding topology of
PITPazPtdCho. The lipid-binding core of the protein is indicated in
blue, the regulatory loop in green, and the C-terminal region in red. The
phospholipid is represented in space-filled spheres using CPK coloring.
b-sheets are labeled 1–8 and a-helices A-G. The figure was generated
with MOLSCRIPT (54) and RASTER3D (55).
TABLE I
X-ray data collection and refinement statistics
Data collection
Space group, Unit cell P21 a 5 43.914 Å, b 5 73.773 Å, c 5 48.185 Å, b 5 114.732°
Beamline NSLS, X12-C
Resolution 2.2 Å
Data set Wave-length
No.
observations
No. unique
reflections Completeness
a I/s Mosaicity Rsym
b
Å % degree %
Peak 0.9791 41,314 13,081 90.1 (67.2) 20.2 (7.2) 0.641 4.5 (8.1)
Edge 0.9794 39,671 12,879 87.4 (60.8) 18.0 (6.2) 0.640 5.1 (9.3)
Remote 0.9500 37,690 12,669 87.8 (64.0) 18.4 (6.4) 0.624 4.6 (8.6)
Refinement
Resolution range (Å) 50.0–2.2
Rcryst (%)
c 21.2
Rfree (%) 25.3
Number of reflectionsd
Working set 11,516 (80.8%)
Test set 629 (4.4%)
Number of atoms
Protein (residues 2–270) 2,228
Lipid (1 molecule PtdCho) 54
Water 55
B values (Å2)
Protein main-chain 17.93
Protein side-chain 21.57
Lipid 35.46
Water 16.29
rms deviations from ideality
Bond length (Å) 0.00826
Bond angle (°) 1.2797
Ramachandran plote
Favored (%) 88.0
Allowed (%) 11.2
Generously allowed (%) 0.4
Disallowed (%) 0.4
a Values in parentheses indicate the highest resolution shell.
b Rsym 5 SuI(hkl) 2 ^I(hkl)&u/SI(hkl).
c Rcryst 5 SuFobs(hkl) 2 Fcalc(hkl)u/SFobs(hkl).
d All data included in calculations of Working set and Test set.
e Glycines and prolines excluded from calculations.
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sive loop region between strands 7 and 8. Postulating that this
loop is likely required for the association of PITP with a wide
variety of lipid- and protein-modifying enzymes, we refer to
this region as the regulatory loop. The recent identification of
Ser166 as a site for limited protein kinase C-dependent phos-
phorylation (32) supports this hypothesis. All PITPs and rdgBs
studied to date contain a regulatory loop region; only Caenor-
habditis elegans PITP lacks the equivalent Ser166 phosphoryl-
ation site. The remaining residues in the structure comprise
the C-terminal residues 233–271. Consisting of the long a-helix
G as the principal secondary structural element and an addi-
tional 11 residues that limit access to the lipid-binding cavity,
we call this region the C-terminal region and suggest its critical
participation in membrane association and dissociation. The
C-terminal region is the least conserved region among the
cytosolic PITPs and is replaced in the rdgB proteins by up to
1000 additional amino acids, some of which appear to be
transmembrane.
Our functional region designation correlates reasonably well
to the location of conserved amino acid residues in the PITP
family (Fig. 1). The majority (nearly 75%) of the absolutely
conserved amino acids are located in the lipid-binding core.
Most of the others are part of the regulatory loop. Consistent
with their proposed functions, both the regulatory loop and the
C-terminal region were predicted to exhibit significant
polypeptide backbone flexibility (33), a structural feature cor-
roborated by specific B factors from the x-ray data.
Characterization of the Lipid-binding Cavity—The residues
in close proximity to the PtdCho head group are shown in Figs.
3 and 4. The majority of these interacting residues are highly
conserved in all PITP and rdgB proteins. Nine water molecules
are within 3.2 Å of the phospholipid or an amino acid residue
lining the phospholipid cavity. The phosphate oxygen O1P
forms hydrogen bonds with the NZ atom of the conserved
Lys195 and a water molecule, and oxygen O2P hydrogen bonds
with the OG1 atom of the conserved Thr97 and another water
molecule. The solvent-accessible volume of the phospholipid-
binding cavity (calculated with a 1.4 Å probe) is 670 Å3,
whereas the molecular-surface volume is 2725 Å3. The van der
Waals volume of the PtdCho molecule is 671 Å3. Of the 271
residues in the protein, 72 residues (27%) have atoms contrib-
uting to the lipid cavity.
DISCUSSION
Characteristics of the interactions between PITP and the
hydrophobic region of PtdIns and PtdCho molecules have been
described (34–35). Using lipids with defined fatty acyl species
at their sn-1 and sn-2 positions, combined with one or more
fluorescent acyl derivatives (pyrenylacyl, parinaroyl), both
binding to PITP and protein-catalyzed transfer from a vesicle
surface were measured. For the sn-1 group a broad range of
structures could be accommodated, with preference for 14- and
16-carbon saturated or monounsaturated fatty acids; neverthe-
less, 18-carbon polyunsaturated fatty acids were still bound
and transferred. In contrast, the sn-2 group exhibits a more
restricted range, preferring 16- and 18-carbon mono- and poly-
unsaturated fatty acids whose double bonds were toward the
FIG. 4. The phospholipid-binding pocket. Residues and water
molecules within 3.9 Å of the PtdCho ligand are indicated. Hydrogen
bonds with the polar head group are indicated by dashed lines. Water
molecules are indicated by small spheres. The sn-1 acyl chain is on the
right, and the sn-2 acyl chain is on the left. The figure was generated
with LIGPLOT (56).
FIG. 3. A stereo diagram of the electron density map in the vicinity of the choline group in the lipid-binding core. An omit map was
calculated in which all phospholipid and water atoms were removed and one cycle of simulated annealing was run prior to the 2Fo-Fc electron
density calculation. Electron density surrounding the PtdCho molecule is green, around the water molecules is light blue, and around the protein
amino acids is brown. All maps are contoured at 1.0 s. Protein atoms are represented as thick sticks using CPK coloring and water molecules are
represented by small red spheres.
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methyl-end of the lipids. PtdCho molecules containing arachi-
donate (20:4n-6) or docosahexaenoate (22:6n-3) in the sn-2 po-
sition bind weakly to PITP. It was suggested that the sn-2
binding site in PITP was “bottle-shaped,” with the neck toward
the ester linkage. Little difference was observed for acyl chain
preferences between the PtdIns and PtdCho class of
phospholipids.
In the PITP structure reported here, the PtdCho ligand con-
tains two oleate (18:1n29) acyl groups. The conformation of the
sn-2 acyl chain is more extended than the sn-1 chain, such that
the sn-2 group extends almost to the surface of the protein. The
lipid cavity follows the contour of the sn-2 acyl chain closely,
but the cavity around the sn-1 chain is less confining. These
features may explain the poor binding of phospholipid mole-
cules with sn-2 acyl moieties longer than 18 carbons and the
less restrictive range of groups accommodated in the sn-1 acyl
region of the cavity.
PITP preferentially binds PtdIns and PtdCho. Whereas
PtdCho was used in the experimental protocol, inositol can be
readily modeled into the electron density for the choline moiety
(except for the sugar hydroxyls). There are numerous charged
or polar amino acid residues in the region that may be potential
hydrogen bonding partners to the inositol hydroxyls (Fig. 5).
Nevertheless, the tertiary structure of the model does not com-
pletely explain polar head group specificity of PITP, for which
further studies are needed.
Conformation, Stability, and Function of the C-terminal Re-
gion—To transfer a phospholipid, PITP must first bind to the
membrane, exchange its bound lipid for a membrane lipid, and
then dissociate from the membrane. Previous studies have
shown that there are significant conformational changes in the
C-terminal residues when PITP binds to lipid membranes (21).
Although cytosolic PITP is highly resistant to trypsin digestion,
protein bound to membranes is rapidly cleaved at Arg253 and
Arg259. In the crystal structure these two sites are part of helix
G in the C-terminal region. Studies have shown that generally
sites that are subject to limited proteolytic cleavage by trypsin
assume a loop-like structure with a conformation similar to
that of trypsin inhibitors (36). Thus, this helix must “melt”
prior to cleavage by trypsin, a process facilitated by interaction
with a membrane surface. The relative instability of portions of
this helix is supported by the high B factors calculated for
residues 243–250.
Residues 260–271 also appear to be important for maintain-
ing a tight compact structure. PITPs truncated at residues 253
or 259 have more relaxed conformations than full-length PITP,
defined by increased quenching of Trp fluorescence by acryl-
amide, increased Tyr exposure, increased reactivity of Cys, and
increased anilino-naphthalene sulfonate binding (37). Inspec-
tion of the native structure shows that such changes cannot be
caused by removal and exposure of residues without a confor-
mational change in the remainder of the protein. Several stud-
ies have shown that removal of one or a few amino acids from
the N- or C-terminus of a protein may have a significant effect
on protein stability and/or dynamics without producing major
changes in conformation (38–39). Our data on the conforma-
tion and biological activity of truncated PITPs are consistent
with a critical role of the C-terminus in the complete packing of
the hydrophobic core and folding and stabilization of the native
structure.
The ability of PITP to bind phospholipid substrates is neces-
sary but not sufficient for subsequent phospholipid transfer.
Removal of up to 20 C-terminal residues greatly reduces phos-
pholipid transfer, yet these truncated proteins produced in E.
coli contain PtdGro, or less commonly, phosphatidylethano-
lamine (PtdEtn) with a near normal 1:1 stoichiometry (37, 40).
Hence, residues 254–271 are dispensable for lipid binding,
although they are important in conferring selectivity for PtdIns
and for efficient transfer of phospholipids. It is not immediately
obvious from the PITP structure why phospholipids such as
PtdEtn and phosphatidic acid (PtdOH) are bound and/or trans-
ferred so poorly.
We had earlier reported that residues 260–271 could be
eliminated with variable effects on transfer activity that re-
flected the composition of the membranes employed in the
assay system (41). With membranes containing only PtdCho,
the truncated PITP (1–259) has transfer activity identical to
the full-length protein. However, with as little as 2% PtdOH in
the donor and/or acceptor membranes, transfer activity de-
creases to 0–20% relative to that observed with PtdCho mem-
branes. Such concentrations have minimal effect on transfer by
native PITP. We demonstrated that this and the more exten-
sively truncated PITP (1–253) have greatly enhanced affinities
for membrane binding, which would result in inefficient lipid
transfer activity. We suggest that the C-terminal region of
PITP acts to maintain a low affinity of the full-length protein
for membranes, especially those containing acidic phospholip-
ids. Structural perturbations within the C-terminal region lead
to enhanced electrostatic interactions and increased membrane
affinity (41).
Structure-Function Correlation of Point Mutations—Knowl-
edge of the tertiary structure of PITP provides an opportunity
to evaluate studies describing and characterizing the random
mutagenesis of the cDNA encoding rat PITPa (42). Mutations
of amino acids Ser25, Thr59, Pro78, and Glu248 were, in general,
observed to abolish PtdIns transfer, whereas PtdCho transfer
was not affected. With the exception of Ser25, all are absolutely
conserved among PITPs and rdgBs. Our data support a role of
the Thr59 hydroxyl group in a putative hydrogen bonding in-
teraction with the inositol moiety (Fig. 5) and place Ser25 in the
vicinity of the fatty acid-glycerol ester linkages. Glu248 makes a
salt bridge with the conserved Lys61 in a region close to the
FIG. 5. PtdIns modeled into the
electron density map of PITPaz
PtdCho. Only electron density from the
final 2Fo-Fc map surrounding the PtdCho
is shown.
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choline and inositol polar head group moieties. Pro78 is near the
end of the portion of the cavity that accommodates the sn-2 acyl
chain. Why mutations of these residues impact selectively and
variably on PtdIns binding and transfer remains unresolved.
Mutations to Glu6 and Pro12, two absolutely conserved resi-
dues, yield poor expression of recombinant mammalian PITP in
a yeast host (42). Based on our structure, these residues likely
stabilize the association between the lipid-binding core and the
regulatory loop. Glu6 participates in salt bridges with the con-
served Arg8 and with His127; similarly, Pro12 packs tightly
against the conserved Leu174.
Membrane Binding and Mechanism of Phospholipid Trans-
fer—Analysis of the exterior features of PITP, such as charge
distribution and hydrophobicity, provided little insight into
what region might constitute the membrane-binding surface.
We presently favor a model in which the C-terminal region is a
part of this surface. In the interaction between protein and
membrane, most if not all of the C-terminal region must be
displaced from helix A in the lipid-binding core and acquire
increased backbone flexibility sufficient to melt a portion of
helix G and become sensitive to proteolytic digestion. We fur-
ther envision that the refolding and reassociation of the C-
terminal region with the bulk protein provides a driving force
for eventual dissociation of PITP from the membrane surface.
The detailed mechanism by which PITP releases its bound
lipid, exchanges it for another present in the membrane surface
and dissociates from the membrane remains to be elucidated. A
plausible model is one in which the C-terminal region of the
protein binds to the membrane and the lipid-binding core
opens, somewhat like a clam shell, exposing its bound lipid to
the membrane surface. The protein-bound lipid is absorbed
into the membrane and replaced by a membrane lipid. Subse-
quently, the C-terminal region refolds and reassociates with
the body of the protein, i.e. the clam shell closes, and the
protein dissociates from the membrane surface. The affinity for
the membrane surface and the affinity for a specific phospho-
lipid must not be too great, otherwise dissociation and transfer
would be too slow and inefficient. As suggested above, the
decreased rate of membrane dissociation, at least in part,
makes C-terminal-truncated PITP derivatives weak catalysts
of lipid exchange with membranes containing acidic
phospholipids.
To account for other biological activities of PITP, we suggest
that the protein-bound phospholipid becomes accessible to
phosphorylation following interaction of a lipid kinase with a
complementary site on PITP, perhaps on the regulatory loop.
One-third of the residues within this 72-amino acid segment
are identical or .90% conserved among all PITP and rdgB
proteins (Fig. 1). Protein-protein interactions are proposed to
alter the conformation of PITP at the head group region of the
lipid-binding core (Fig. 6). This could lead to either the presen-
tation of PtdIns to the active site of a membrane-bound PtdIns
4-kinase or the exposure of the inositol moiety of a PITP-bound
PtdIns to the action of a soluble PtdIns 3-kinase or 4-kinase
(43–44). Evidence supporting such a function of PITP in sub-
strate presentation to a PtdIns 3-kinase has been reported (10).
Following modification of the inositol 3- or 4-hydroxyl function,
the affinity of the product for PITP would likely decrease so
significantly that it would remain with the kinase or return to
the lipid surface. Consistent with this mechanism is the inabil-
ity of PITP to bind and transfer PtdIns (4)P (45).
Comparison with other Lipid-binding Proteins—Using the
DALI algorithm (30) to search for proteins structurally similar
to PITP, the recently described START (StAR-related lipid-
transfer) domain (46) was identified as sharing significant ter-
tiary structure. MLN64 (PDB:1EM2), a protein associated with
some human breast carcinomas, has served as a prototype for
structure determination and mechanistic studies of the START
domain (47). The MLN64 START domain contains a hydropho-
bic tunnel that extends the length of the protein with small
openings on both ends. A nine-stranded antiparallel b-sheet
and two a-helices form an interior hydrophobic chamber that is
believed to be just large enough to accommodate a single mol-
ecule of cholesterol. Cholesterol was not included in the crys-
tallization solutions, but docked into the finished protein
model. START domain proteins are proposed to bind lipids and
interact with membranes, properties also common to PITPs.
Steroidogenic acute regulatory (StAR) protein, whose function
is to deliver cholesterol to the inner mitochondrial membrane
and cytochrome P450scc, contains a START domain near its
C-terminus. Nearly the entire sequence of PtdCho transfer
protein (PCTP), another cytosolic lipid transfer protein, consti-
FIG. 6. Schematic of interaction of PITP with membrane sur-
faces and other proteins. A, protein-catalyzed phospholipid exchange
and transport between membranes. B, interaction of a membrane-
bound PITP and cytosolic PtdIns 3-kinase. C, interaction of PITP with
a membrane-bound PtdIns 4-kinase.
FIG. 7. Stereo diagram of the super-
position of the Ca atoms of the
PITPazPtdCho lipid-binding core and
the START domain of MLN64. The
PITP trace is blue, and the MLN64 trace
is red. The PtdCho molecule of
PITPazPtdCho is shown in sticks.
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tutes a single START domain. In contrast to PITP, PCTP has a
marked specificity for PtdCho and highly restricted tissue ex-
pression in mammals (2). Although not identified by the DALI
search, the recently reported structure of sterol carrier pro-
tein-2 (PDB 1QND, Ref. 48) is another example of a protein
with a lipid-binding core similar to that observed in MLN64
and PITP.
Despite reasonable similarity at the secondary and tertiary
levels of structure (Fig. 7), there is no primary structure ho-
mology between members of the PITP family and proteins with
a START domain. It should be noted that the lipid cavity in
PITP is larger than the cavity in MLN64. Upon superposition,
one of the a-helices comprising the putative lipid-binding cav-
ity of MLN64 clashes with the sn-1 acyl chain of the bound
PtdCho in the PITP structure. This is not surprising in that
PITP binds diacyl phospholipids, whereas MLN64 binds the
more compact cholesterol molecule. The START and PITP pro-
tein families represent an excellent example of functional evo-
lutionary convergence to generate comparable domain archi-
tecture and related biological function from apparently
unrelated genetic information.
Fungi and plants contain Sec14p, a cytosolic protein that
transports PtdIns and PtdCho (13, 49–52) and is required for
protein export and cell viability. Recently, the three-dimen-
sional structure of Saccharomyces cerevisiae Sec14p, one mem-
ber of this conserved family, was reported (53). PITP and
Sec14p are similar in size, exhibit similar in vitro lipid-binding
specificity and transport abilities and display significant and
highly complementary interspecies activity. However, the two
proteins have little structural similarity. In contrast to the
PITPazPtdCho structure, Sec14p structure has no bound phos-
pholipid molecule.
Conclusions—Elucidation of the PITPazPtdCho structure re-
veals a complex amphipathic lipid completely enclosed within a
folded polypeptide cavity. The three functional regions of the
protein provides a molecular framework for understanding the
details of protein-lipid interactions on several levels. Within its
lipid-binding core, PITP has been shown to sequester phospho-
lipids from the aqueous environment. Lipid ligand specificity,
whereas not completely explained by the tertiary structure, is
dictated by extensive noncovalent interactions. The C-terminal
region of PITP is proposed to promote the transient association
to and dissociation from lipid surfaces. Through its regulatory
loop, PITP is thought to present lipid substrates to kinases for
subsequent phosphorylation. Further mutagenic and struc-
tural studies of PITP and other members of the PITP-rdgB
family are required to test these and other hypotheses. De-
tailed analyses of PITP interactions with membranes and ki-
nases are needed to gain a more meaningful understanding of
the role of PITP in cellular phospholipid metabolism.
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